Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

MD Medical Group MDMG Announcement of the Lapino Hospital Opening



  MD Medical Group (MDMG) - Announcement of the Lapino Hospital Opening

RNS Number : 9629R
MD Medical Group Investments PLC
26 November 2012
 



                                       

 

                

                               MD MEDICAL GROUP

                     ANNOUNCES OPENING OF LAPINO HOSPITAL

                                       

 

26 November 2012 - MD Medical Group Investments Plc ("MD Medical Group" or the
"Company" -  LSE:  MDMG), Russia's leading  provider  of private  women's  and 
children's healthcare,  announces  today  that it  has  received  the  licence 
required to operate  its new  state-of-the-art Lapino hospital  in the  Moscow 
Region, and will  be ready  to receive  its first  patients as  of Monday,  26 
November 2012.

 

Commenting on  the opening  of the  Lapino hospital,  Chairman of  MD  Medical 
Group,
Dr Mark Kurtser said:

 

"The day when Lapino would open its doors to its first patients is the day  we 
have all been waiting for. I have  long wanted to create a new medical  centre 
where  patients  would  be  treated  in  the  most  comfortable  and  friendly 
environment; where  women could  deliver  in the  best conditions;  and  where 
doctors could work with  the most sophisticated equipment.  I am proud of  the 
fact that we continue to  be the only company in  Russia to have succeeded  in 
building and operating  purpose-built, modern medical  centres. Lapino is  our 
second such hospital, representing  a US$ 150 million  investment, and we  are 
happy that it is opening on schedule."

 

Chief Executive Officer of MD Medical Group, Dr Elena Mladova added:

 

"We continue to see strong demand for high-quality medical services in Russia,
and particularly note the year-on-year growth  in the number of deliveries  in 
Moscow and the Moscow region. These trends create a very favourable  operating 
environment for our company. The number  of deliveries at our existing  clinic 
has reached 2,900 year-to-date, already more than for the full-year 2011,  and 
we are operating at full capacity.

 

"The new state-of-the-art, 182-bed  medical centre is  located in an  affluent 
Moscow suburban area and, in addition to maternity care and paediatrics,  will 
focus on diagnostics, trauma, therapy and rehabilitation. The annual  capacity 
of the new hospital  will be 400,000 outpatient  visits and 3,000  deliveries. 
 Our medical personnel are  fully prepared to accept  their first patients  in 
Lapino, while management  is focused on  ensuring the dynamic  ramp up of  the 
clinic."

 

The ceremonial opening of the new hospital took place on Saturday, 24 November
2012. Among those  who came to  congratulate the Company  were Olga  Golodets, 
Deputy Prime  Minister of  Russia,  Andrey Vorobyev,  Acting Governor  of  the 
Moscow region, Andrey Kostin, Chairman of VTB, and Kirill Dmitriev, CEO of the
Russian Direct Investment Fund.

 

ENDS

 

Learn  more  about  MD  Medical  Group.  Visit  the  Company's  web  site   at 
www.mcclinics.com

 

 

For further information please contact:

                                            

Media                                      Investors
MD Medical Group                           Andrey Braginskiy
Anastasia Anichenkova                      Tel: +7 985 211 7478
Tel: +7 495 332 6670 / +7 916 661 6242     ir@mospmc.ru
a.anichenkova@mospmc.ru
M:Communications
Tom Blackwell / Anna Yarmarkova - Moscow
Tel: +7 495 363 2846
mdmg@mcomgroup.com
Sarah Macleod / Mary-Jane Elliott - London
Tel: +44 20 7920 2300
mdmg@mcomgroup.com

 

* * *

About MD Medical Group

 

MD Medical Group operates in the highly attractive Russian private  healthcare 
service market and has a leading  position in high-quality women's health  and 
paediatrics. The company manages  ten modern healthcare facilities,  including 
two hospitals and eight outpatient clinics in Moscow, St. Petersburg, Ufa  and 
Perm. In addition, two franchised outpatient  clinics operate in Kyiv and  one 
franchised outpatient clinic in Irkutsk. In 2013, the Company expects to begin
construction of its third hospital in Ufa.

 

The Company's first hospital,  the Perinatal Medical  Center (PMC), a  250-bed 
medical facility  opened  its  doors  in  2006.  In  2011,  there  were  2,859 
deliveries in PMC. The number of outpatient treatments for 2011 in PMC and the
Company's outpatient clinics totalled 314,098.

 

As of  June  30,  2012,  the  Company  employed  approximately  1,461  medical 
specialists and staff.  The  Company's shares have been  listed on the  London 
Stock Exchange(LSE ticker "MDMG")  in the form  of Global Depositary  Receipts 
(GDRs) since October 12, 2012.

 

.* * *

 

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the
Company's current  expectations  and assumptions  and  may involve  known  and 
unknown risks and uncertainties that  could cause actual results,  performance 
or events  to  differ materially  from  those  expressed or  implied  in  such 
statements. The forward looking statements contained in this press release are
based on  past trends  or activities  and should  not be  taken as  a  repress 
release that such  trends or  activities will continue  in the  future. It  is 
believed that the expectations reflected  in these statements are  reasonable, 
but they may be  affected by a  number of variables  which could cause  actual 
results or  trends  to  differ  materially, including,  but  not  limited  to: 
conditions in the market, market position of the Company, earnings,  financial 
position, cash flows,  return on  capital and  operating margins,  anticipated 
investments  and  economic  conditions;   the  Company's  ability  to   obtain 
capital/additional finance; a reduction in demand by customers; an increase in
competition; an unexpected decline  in revenue or profitability;  legislative, 
fiscal and regulatory developments, including, but not limited to, changes  in 
environmental and health and  safety regulations; exchange rate  fluctuations; 
retention  of  senior  management;   the  maintenance  of  labour   relations; 
fluctuations  in  the  cost  of  input  costs;  and  operating  and  financial 
restrictions as a result of financing arrangements.

No statement  in  this  press  release is  intended  to  constitute  a  profit 
forecast, nor should any  statements be interpreted to  mean that earnings  or 
earnings per share will  necessarily be greater or  lesser than those for  the 
relevant preceding financial  periods for  the Company.  Each forward  looking 
statement relates only as of the date of the particular statement.

                     This information is provided by RNS
           The company news service from the London Stock Exchange
 
END
 
 
MSCEAKFKAENAFEF -0- Nov/26/2012 07:00 GMT
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement